BETA DRUGS
|
BETA DRUGS Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹362 Cr | ₹296 Cr | ₹227 Cr | ₹184 Cr | ₹116 Cr |
| Sales | ₹362 Cr | ₹296 Cr | ₹227 Cr | ₹184 Cr | ₹116 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | - | - | - | - | - |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹362 Cr | ₹296 Cr | ₹227 Cr | ₹184 Cr | ₹116 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-4.42 Cr | ₹-18 Cr | ₹-4.71 Cr | ₹-1.75 Cr | ₹-1.77 Cr |
| Raw Material Consumed | ₹176 Cr | ₹168 Cr | ₹110 Cr | ₹96 Cr | ₹61 Cr |
| Opening Raw Materials | ₹10 Cr | ₹7.98 Cr | ₹6.24 Cr | ₹3.64 Cr | ₹2.65 Cr |
| Purchases Raw Materials | ₹181 Cr | ₹170 Cr | ₹112 Cr | ₹99 Cr | ₹62 Cr |
| Closing Raw Materials | ₹15 Cr | ₹10 Cr | ₹7.98 Cr | ₹6.24 Cr | ₹3.64 Cr |
| Other Direct Purchases / Brought in cost | - | - | - | - | - |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹5.29 Cr | ₹4.48 Cr | ₹3.43 Cr | ₹2.80 Cr | ₹2.36 Cr |
| Electricity & Power | ₹5.29 Cr | ₹4.48 Cr | ₹3.43 Cr | ₹2.80 Cr | ₹2.36 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹27 Cr | ₹20 Cr | ₹17 Cr | ₹12 Cr | ₹8.32 Cr |
| Salaries, Wages & Bonus | ₹23 Cr | ₹17 Cr | ₹15 Cr | ₹10 Cr | ₹6.90 Cr |
| Contributions to EPF & Pension Funds | ₹1.81 Cr | ₹1.51 Cr | ₹1.26 Cr | ₹0.89 Cr | ₹0.65 Cr |
| Workmen and Staff Welfare Expenses | ₹1.28 Cr | ₹0.73 Cr | ₹0.60 Cr | ₹0.39 Cr | ₹0.26 Cr |
| Other Employees Cost | ₹0.48 Cr | ₹0.48 Cr | ₹0.47 Cr | ₹0.71 Cr | ₹0.52 Cr |
| Other Manufacturing Expenses | ₹36 Cr | ₹27 Cr | ₹20 Cr | ₹14 Cr | ₹10 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹22 Cr | ₹17 Cr | ₹12 Cr | ₹8.90 Cr | ₹6.45 Cr |
| Repairs and Maintenance | ₹4.00 Cr | ₹2.80 Cr | ₹1.87 Cr | ₹1.01 Cr | ₹0.72 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹9.98 Cr | ₹7.71 Cr | ₹6.43 Cr | ₹4.57 Cr | ₹3.25 Cr |
| General and Administration Expenses | ₹30 Cr | ₹24 Cr | ₹19 Cr | ₹11 Cr | ₹7.12 Cr |
| Rent , Rates & Taxes | ₹1.13 Cr | ₹1.05 Cr | ₹1.25 Cr | ₹0.66 Cr | ₹0.81 Cr |
| Insurance | ₹1.11 Cr | ₹0.86 Cr | ₹0.47 Cr | ₹0.57 Cr | ₹0.22 Cr |
| Printing and stationery | ₹1.36 Cr | ₹1.07 Cr | ₹0.74 Cr | ₹0.37 Cr | ₹0.18 Cr |
| Professional and legal fees | ₹3.18 Cr | ₹2.64 Cr | ₹1.97 Cr | ₹1.23 Cr | ₹0.83 Cr |
| Traveling and conveyance | ₹12 Cr | ₹8.64 Cr | ₹6.83 Cr | ₹3.41 Cr | ₹1.71 Cr |
| Other Administration | ₹11 Cr | ₹9.48 Cr | ₹7.70 Cr | ₹4.67 Cr | ₹3.38 Cr |
| Selling and Distribution Expenses | ₹17 Cr | ₹9.66 Cr | ₹7.12 Cr | ₹5.84 Cr | ₹3.86 Cr |
| Advertisement & Sales Promotion | ₹3.56 Cr | ₹1.46 Cr | ₹1.26 Cr | ₹0.80 Cr | ₹0.67 Cr |
| Sales Commissions & Incentives | ₹6.20 Cr | ₹4.83 Cr | ₹3.05 Cr | ₹2.26 Cr | ₹0.56 Cr |
| Freight and Forwarding | ₹6.42 Cr | ₹3.10 Cr | ₹2.54 Cr | ₹2.46 Cr | ₹1.76 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | ₹0.32 Cr | ₹0.27 Cr | ₹0.28 Cr | ₹0.33 Cr | ₹0.87 Cr |
| Miscellaneous Expenses | ₹1.74 Cr | ₹0.95 Cr | ₹1.29 Cr | ₹0.56 Cr | ₹0.53 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | - | - | - | - | - |
| Losson disposal of fixed assets(net) | - | ₹0.00 Cr | - | - | ₹0.00 Cr |
| Losson foreign exchange fluctuations | - | ₹-0.08 Cr | ₹0.31 Cr | - | ₹0.01 Cr |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹1.74 Cr | ₹1.03 Cr | ₹0.99 Cr | ₹0.56 Cr | ₹0.52 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹288 Cr | ₹236 Cr | ₹174 Cr | ₹141 Cr | ₹91 Cr |
| Operating Profit (Excl OI) | ₹75 Cr | ₹60 Cr | ₹53 Cr | ₹43 Cr | ₹25 Cr |
| Other Income | ₹6.44 Cr | ₹1.36 Cr | ₹0.75 Cr | ₹0.76 Cr | ₹0.50 Cr |
| Interest Received | ₹5.11 Cr | ₹1.08 Cr | ₹0.66 Cr | ₹0.45 Cr | ₹0.33 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | - | - | - |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | - | - | - | ₹0.04 Cr | ₹0.01 Cr |
| Others | ₹1.33 Cr | ₹0.28 Cr | ₹0.09 Cr | ₹0.26 Cr | ₹0.16 Cr |
| Operating Profit | ₹81 Cr | ₹61 Cr | ₹54 Cr | ₹43 Cr | ₹25 Cr |
| Interest | ₹6.99 Cr | ₹2.82 Cr | ₹2.42 Cr | ₹1.90 Cr | ₹2.42 Cr |
| InterestonDebenture / Bonds | ₹3.16 Cr | - | - | - | - |
| Interest on Term Loan | ₹1.16 Cr | ₹0.67 Cr | ₹0.91 Cr | ₹1.03 Cr | ₹1.19 Cr |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹0.25 Cr | ₹0.14 Cr | ₹0.14 Cr | ₹0.11 Cr | ₹0.20 Cr |
| Other Interest | ₹2.42 Cr | ₹2.01 Cr | ₹1.37 Cr | ₹0.76 Cr | ₹1.03 Cr |
| PBDT | ₹74 Cr | ₹59 Cr | ₹51 Cr | ₹42 Cr | ₹23 Cr |
| Depreciation | ₹13 Cr | ₹9.78 Cr | ₹10 Cr | ₹7.25 Cr | ₹6.87 Cr |
| Profit Before Taxation & Exceptional Items | ₹62 Cr | ₹49 Cr | ₹41 Cr | ₹34 Cr | ₹16 Cr |
| Exceptional Income / Expenses | ₹-4.57 Cr | - | - | - | - |
| Profit Before Tax | ₹57 Cr | ₹49 Cr | ₹41 Cr | ₹34 Cr | ₹16 Cr |
| Provision for Tax | ₹15 Cr | ₹12 Cr | ₹10 Cr | ₹9.47 Cr | ₹4.23 Cr |
| Current Income Tax | ₹15 Cr | ₹13 Cr | ₹11 Cr | ₹9.51 Cr | ₹4.71 Cr |
| Deferred Tax | ₹-0.42 Cr | ₹-0.21 Cr | ₹-0.52 Cr | ₹-0.03 Cr | ₹-0.48 Cr |
| Other taxes | - | - | - | - | - |
| Profit After Tax | ₹42 Cr | ₹36 Cr | ₹31 Cr | ₹25 Cr | ₹12 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | - | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹42 Cr | ₹36 Cr | ₹31 Cr | ₹25 Cr | ₹12 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹124 Cr | ₹89 Cr | ₹59 Cr | ₹35 Cr | ₹24 Cr |
| Appropriations | ₹166 Cr | ₹126 Cr | ₹90 Cr | ₹60 Cr | ₹35 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹2.45 Cr | ₹2.20 Cr | ₹0.18 Cr | ₹1.10 Cr | ₹0.22 Cr |
| Equity Dividend % | - | - | - | - | - |
| Earnings Per Share | ₹42.02 | ₹37.90 | ₹31.95 | ₹25.82 | ₹12.20 |
| Adjusted EPS | ₹42.02 | ₹36.10 | ₹30.43 | ₹24.60 | ₹11.61 |
Compare Income Statement of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,327.2 Cr | 5.4% | 49.7% | 22.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 5.4% |
49.7% |
22.8% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses